PNNL has developed seaweed-based inks and materials for 2-D and 3-D printing that can be used for a multitude of applications in the art, medical, STEM, and other fields.
A comprehensive literature review linking algae and antivirals determines compounds in algae may demonstrate an exceptional—and as yet untapped—potential to combat viral diseases at every point along the viral infection pathway.
A Q&A with Lauren Charles, veterinarian and PNNL data scientist, on zoonotic diseases and the role biosurveillance plays in mitigating the growing threat to global health.
Three recent doctoral graduates are beginning their research careers at Pacific Northwest National Laboratory after completing the WSU-PNNL Distinguished Graduate Research Program this spring.
High school students from across Washington State competed in the Pacific Northwest Regional Science Bowl, hosted online by PNNL, for a chance to advance to the national competition in May.
PNNL highlights four researchers whose joint appointments are creating new and diverse opportunities for expanding knowledge and scientific impact across institutions.
PNNL computational biologists, structural biologists, and analytical chemists are using their expertise to safely accelerate the design step of the COVID-19 drug discovery process.
Researchers at PNNL have developed a bacteria testing system called OmniScreen that combines biological and synthetic chemistry with machine learning to hunt down pathogens before they strike.
An award-winning ion separation technology developed at PNNL has been licensed for biomedical applications. Continued research aims to make the devices suitable for molecular analysis in the field.
Using a large repository of blood samples from military personnel, PNNL and Uniformed Services University scientists have discovered a group of 13 proteins that could provide early detection of head and neck cancers.